Genex Pharmaceutical, Inc. (GENX)
OTCMKTS · Delayed Price · Currency is USD
0.0002
0.00 (0.00%)
At close: Oct 29, 2026

Genex Pharmaceutical Statistics

Total Valuation

GENX has a market cap or net worth of 3,569.

Market Cap3,569
Enterprise Value n/a

Important Dates

Earnings Date n/a
Ex-Dividend Date n/a

Share Statistics

GENX has 17.85 million shares outstanding.

Current Share Class 17.85M
Shares Outstanding 17.85M
Shares Change (YoY) n/a
Shares Change (QoQ) n/a
Owned by Insiders (%) n/a
Owned by Institutions (%) n/a
Float n/a

Valuation Ratios

The trailing PE ratio is 0.01.

PE Ratio 0.01
Forward PE n/a
PS Ratio 0.00
PB Ratio 0.00
P/TBV Ratio 0.00
P/FCF Ratio 0.01
P/OCF Ratio 0.01
PEG Ratio n/a

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 0.62, with a Debt / Equity ratio of 0.12.

Current Ratio 0.62
Quick Ratio 0.48
Debt / Equity 0.12
Debt / EBITDA 1.10
Debt / FCF 1.09
Interest Coverage n/a

Financial Efficiency

Return on equity (ROE) is 7.78% and return on invested capital (ROIC) is 4.44%.

Return on Equity (ROE) 7.78%
Return on Assets (ROA) 4.05%
Return on Invested Capital (ROIC) 4.44%
Return on Capital Employed (ROCE) 9.01%
Weighted Average Cost of Capital (WACC) -1.75%
Revenue Per Employee 37,641
Profits Per Employee 3,983
Employee Count 86
Asset Turnover 0.45
Inventory Turnover 0.77

Taxes

In the past 12 months, GENX has paid 391,037 in taxes.

Income Tax 391,037
Effective Tax Rate 53.30%

Stock Price Statistics

Beta (5Y) -52.29
52-Week Price Change n/a
50-Day Moving Average 0.00
200-Day Moving Average 0.01
Relative Strength Index (RSI) 32.64
Average Volume (20 Days) 31,188

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, GENX had revenue of 3.24 million and earned 342,549 in profits. Earnings per share was 0.02.

Revenue 3.24M
Gross Profit 2.87M
Operating Income 466,137
Pretax Income 733,586
Net Income 342,549
EBITDA 522,276
EBIT 466,137
Earnings Per Share (EPS) 0.02

Balance Sheet

The company has 430,124 in cash and 574,980 in debt, with a net cash position of -144,856 or -0.01 per share.

Cash & Cash Equivalents 430,124
Total Debt 574,980
Net Cash -144,856
Net Cash Per Share -0.01
Equity (Book Value) 4.74M
Book Value Per Share 0.27
Working Capital -1.34M

Cash Flow

In the last 12 months, operating cash flow was 529,657 and capital expenditures -1,252, giving a free cash flow of 528,405.

Operating Cash Flow 529,657
Capital Expenditures -1,252
Depreciation & Amortization 56,139
Net Borrowing 555,798
Free Cash Flow 528,405
FCF Per Share 0.03

Margins

Gross margin is 88.80%, with operating and profit margins of 14.40% and 10.58%.

Gross Margin 88.80%
Operating Margin 14.40%
Pretax Margin 22.66%
Profit Margin 10.58%
EBITDA Margin 16.13%
EBIT Margin 14.40%
FCF Margin 16.32%

Dividends & Yields

GENX does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
FCF Payout Ratio n/a
Buyback Yield n/a
Shareholder Yield n/a
Earnings Yield 9,597.50%
FCF Yield 14,805.41%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

The last stock split was on July 1, 2004. It was a forward split with a ratio of 4.

Last Split Date Jul 1, 2004
Split Type Forward
Split Ratio 4

Scores

GENX has an Altman Z-Score of 1.53 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score 1.53
Piotroski F-Score 4